92 related articles for article (PubMed ID: 2986351)
1. [The degree of differentiation and the clinical course of ovarian cancer].
Vinokurov VL; Iurkova LE; Zagol'skaia VN
Vopr Onkol; 1985; 31(3):55-63. PubMed ID: 2986351
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-prognostic factors in cancer of the ovaries].
Ali-Zade VA; Atakishiev AR
Vopr Onkol; 1990; 36(8):1005-6. PubMed ID: 2171225
[No Abstract] [Full Text] [Related]
3. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
5. Biologic behavior of primary ovarian malignancy.
Julian CG; Goss J; Blanchard K; Woodruff JD
Obstet Gynecol; 1974 Dec; 44(6):873-84. PubMed ID: 4373686
[No Abstract] [Full Text] [Related]
6. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
7. [Degree of differentiation of ovarian cancer and its clinical significance].
Zagol'skaia VN; Vinokurov VL; Nechaeva ID; Pozharisskiĭ KM; Iurkova LE
Vopr Onkol; 1985; 31(9):62-70. PubMed ID: 2996225
[TBL] [Abstract][Full Text] [Related]
8. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
9. [Histologic type and tumor maturity as prognostic factors in malignant epithelial tumors of the ovary].
Jukić S; Ilić J; Krstulović B; Krznar B; Culig V
Jugosl Ginekol Perinatol; 1989; 29(3-4):137-9. PubMed ID: 2601368
[TBL] [Abstract][Full Text] [Related]
10. [Staging and grading experiences in ovarian carcinoma and their prognostic value].
Bartl W; Janisch H; Szalay S; Szepesi T; Tatra G; Breitenecker G
Gynakol Rundsch; 1982; 22(2):158-64. PubMed ID: 6286427
[No Abstract] [Full Text] [Related]
11. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.
Barber HR; Sommers SC; Synder R; Kwon TH
Am J Obstet Gynecol; 1975 Mar; 121(6):795-807. PubMed ID: 1092171
[TBL] [Abstract][Full Text] [Related]
12. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages.
O'Brien ME; Schofield JB; Tan S; Fryatt I; Fisher C; Wiltshaw E
Gynecol Oncol; 1993 May; 49(2):250-4. PubMed ID: 8504995
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in stage I ovarian carcinoma.
Vergote I
Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
Provenza C; Young RH; Prat J
Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of histological variants of adenosquamous carcinoma of the corpus uteri].
Smirnov OA
Vopr Onkol; 1984; 30(3):32-7. PubMed ID: 6710946
[TBL] [Abstract][Full Text] [Related]
17. Results of postoperative megavoltage radiotherapy of malignant surface epithelial tumors of the ovary.
Hintz BL; Fuks Z; Kempson RL; Eltringham JR; Zaloudek C; Williamson TJ; Bagshaw MA
Radiology; 1975 Mar; 114(3):695-700. PubMed ID: 164041
[TBL] [Abstract][Full Text] [Related]
18. Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
Int J Gynecol Pathol; 2011 Sep; 30(5):431-41. PubMed ID: 21804390
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
